molecular function |
| GO:0005179 | | hormone activity | | The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process. |
| GO:0031710 | | neuromedin B receptor binding | | Interacting selectively and non-covalently with a neuromedin B receptor. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
biological process |
| GO:0050482 | | arachidonic acid secretion | | The controlled release of arachidonic acid from a cell or a tissue. |
| GO:0007267 | | cell-cell signaling | | Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions. |
| GO:0042593 | | glucose homeostasis | | Any process involved in the maintenance of an internal steady state of glucose within an organism or cell. |
| GO:0046888 | | negative regulation of hormone secretion | | Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of a hormone from a cell. |
| GO:0007218 | | neuropeptide signaling pathway | | The series of molecular signals generated as a consequence of a peptide neurotransmitter binding to a cell surface receptor. |
| GO:0008284 | | positive regulation of cell proliferation | | Any process that activates or increases the rate or extent of cell proliferation. |
| GO:0007204 | | positive regulation of cytosolic calcium ion concentration | | Any process that increases the concentration of calcium ions in the cytosol. |
| GO:0046887 | | positive regulation of hormone secretion | | Any process that activates or increases the frequency, rate or extent of the regulated release of a hormone from a cell. |
| GO:0007165 | | signal transduction | | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
cellular component |
| GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| GO:0043005 | | neuron projection | | A prolongation or process extending from a nerve cell, e.g. an axon or dendrite. |